Editorial: Alzheimer’s disease

Editorial: Alzheimer’s disease

Saved in:

Bibliographic Details
Main Author:	Ryszard Pluta
Format:	Article
Language:	English
Published:	Open Exploration Publishing Inc. 2025-06-01
Series:	Exploration of Neuroscience
Subjects:	alzheimer’s disease biomarkers apolipoprotein e neuroimaging treatments phenolic compounds hydrophobic peptides neurostimulation
Online Access:	https://www.explorationpub.com/uploads/Article/A100694/100694.pdf
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Increased cerebrospinal fluid and plasma apoE glycosylation is associated with reduced levels of Alzheimer’s disease biomarkers
by: Dobrin Nedelkov, et al.
Published: (2025-07-01)

Research progress on the mechanisms of apolipoprotein E in Alzheimer’s disease
by: Jiayuan Li, et al.
Published: (2025-01-01)

HDL‐Apolipoprotein in Alzheimer's Disease Revisited: From Periphery to CNS
by: Yihong Huang, et al.
Published: (2025-04-01)

Apolipoprotein E dysfunction in Alzheimer’s disease: a study on miRNA regulation, glial markers, and amyloid pathology
by: Printha Wijesinghe, et al.
Published: (2024-12-01)

Anti-amyloid β hydrophobic peptides in Alzheimer’s disease: biomarkers and therapeutic potential
by: Carlos Gutierrez-Merino
Published: (2025-02-01)

Association of critically short telomeres with brain and blood markers of ageing and Alzheimer’s disease in older adults
by: Asrar Lehodey, et al.
Published: (2024-12-01)

Argentina-Alzheimer's disease neuroimaging initiative (Arg-ADNI): neuropsychological evolution profile after one-year follow up
by: Patricio Chrem Méndez, et al.

Advancements in the treatment of Alzheimer's disease: a comprehensive review
by: Srushti Rajanna, et al.
Published: (2025-04-01)

The APOE–Microglia Axis in Alzheimer’s Disease: Functional Divergence and Therapeutic Perspectives—A Narrative Review
by: Aiwei Liu, et al.
Published: (2025-06-01)

Sex differences in the association of Alzheimer’s disease biomarkers and cognition in a multicenter memory clinic study
by: Cecilia Boccalini, et al.
Published: (2025-02-01)

APOE4 and chronic health risk factors are associated with sex-specific preclinical Alzheimer’s disease neuroimaging biomarkers
by: Genna M. Losinski, et al.
Published: (2025-05-01)

Longitudinal Analysis of Amyloid PET and Brain MRI for Predicting Conversion from Mild Cognitive Impairment to Alzheimer’s Disease: Findings from the ADNI Cohort
by: Do-Hoon Kim
Published: (2025-03-01)

The role of Apolipoprotein E4 on cognitive impairment in Parkinson’s disease and Parkinsonisms
by: Angenelle Eve Rosal, et al.
Published: (2025-02-01)

The Role of APOA-I in Alzheimer’s Disease: Bridging Peripheral Tissues and the Central Nervous System
by: Guanfeng Xie, et al.
Published: (2025-05-01)

Cerebrospinal fluid levels of tumour necrosis factor-α and its receptors are not associated with disease progression in Alzheimer’s disease
by: Manal Aljuhani
Published: (2025-04-01)

Case Report: The Alzheimer’s paradox: a clinically stable amnestic syndrome with full biomarker positivity and minimal imaging evidence
by: Anna-Chloé Balageas, et al.
Published: (2025-08-01)

Modern biomarkers as key tools in the early diagnosis and monitoring of Alzheimer's disease progression
by: Konrad Strużek, et al.
Published: (2025-04-01)

Cross‐sectional study of plasma phosphorylated tau 217 in persons without dementia
by: Toni T. Saari, et al.
Published: (2025-04-01)

APOE ε4 and exercise interact in a sex‐specific manner to modulate dementia risk factors
by: Kate E. Foley, et al.
Published: (2022-01-01)

Apolipoprotein B gene expression and regulation in relation to Alzheimer’s disease pathophysiology
by: Gabriel Aumont-Rodrigue, et al.
Published: (2024-11-01)

Editorial: Advances in epilepsy research: exploring biomarkers, brain stimulation, and neurosurgical interventions
by: Kazuki Sakakura, et al.
Published: (2025-06-01)

Combination therapy targeting Alzheimer's disease risk factors is associated with a significant delay in Alzheimer's disease–related cognitive decline
by: Yuan Shang, et al.
Published: (2025-01-01)

A genetic signature including apolipoprotein Eε4 potentiates the risk of herpes simplex–associated Alzheimer's disease
by: Karin Lopatko Lindman, et al.
Published: (2019-01-01)

Alzheimer's disease pathology explains association between dementia with Lewy bodies and APOE‐ε4/TOMM40 long poly‐T repeat allele variants
by: Inga Prokopenko, et al.
Published: (2019-01-01)

Artificial Intelligence for Alzheimer’s Disease Detection: Enhancing Biomarker Analysis and Diagnostic Precision
by: Richa Gupta, et al.
Published: (2024-11-01)

Discovery of Isobavachin, a Natural Flavonoid, as an Apolipoprotein E4 (ApoE4) Structure Corrector for Alzheimer’s Disease
by: Sachin P. Patil, et al.
Published: (2025-02-01)

Apolipoprotein E4 and Alzheimer's disease in São Paulo - Brazil Apolipoproteina E 4 e doença de Alzheimer em São Paulo - Brasil
by: Osvaldo P. Almeida, et al.
Published: (1997-01-01)

Phenolic compounds as anti-Alzheimer’s disease agents
by: Jorge Medeiros
Published: (2025-06-01)

The Relationship of Some Hormones, Enzymes and Proteins to ALzheimerʹs Disease
by: Shemaa Ayob, et al.
Published: (2024-12-01)

Sleep quality among sample of Egyptian patients with Alzheimer’s disease: risk factors and role of genetic profiling for ACE, ACE 2 and APO E genotypes
by: Khaled Ahmed Elbeh, et al.
Published: (2025-01-01)

Alterations in Olfactory Cortex Volume in Mild Cognitive Impairment and Mild Alzheimer’s Disease Dementia: A Study of Sex-Related Differences
by: Majed M. Alotaibi, et al.
Published: (2025-06-01)

Sex-related differences in genetically determined Alzheimer’s disease
by: Laura Del Hoyo Soriano, et al.
Published: (2025-03-01)

Predicting Alzheimer's Disease onset: A machine learning framework for early diagnosis using biomarker data
by: Shehu Mohammed, et al.
Published: (2025-01-01)

Biomarker Investigation Using Multiple Brain Measures from MRI Through Explainable Artificial Intelligence in Alzheimer’s Disease Classification
by: Davide Coluzzi, et al.
Published: (2025-01-01)

Is MTHFR polymorphism a risk factor for Alzheimer's disease like APOE? Polimorfismo da MTHFR é um fator de risco para demência de Alzheimer como APOE?
by: Liana Lisboa Fernandez, et al.
Published: (2005-03-01)

BDNF expression mediates verbal learning and memory in women in a cohort enriched with risk for Alzheimer's disease
by: Kyle J. Edmunds, et al.
Published: (2025-01-01)

The economic burden of subjective cognitive decline, mild cognitive impairment and Alzheimer's dementia: excess costs and associated clinical and risk factors
by: Eva Gläser, et al.
Published: (2025-06-01)

Alzheimer's disease: part 2 – the present
by: Ricardo Nitrini
Published: (2024-06-01)

Rare APOE p.Gly4Glu: A putative disease-causing variant for early-onset Alzheimer’s disease identified by next-generation sequencing
by: Chu-Ting Wu, et al.
Published: (2025-04-01)

Cerebrospinal Fluid Biomarkers of Alzheimer Disease
by: Kseniya V. Nevzorova, et al.
Published: (2025-06-01)